| scholarly article | Q13442814 |
| P50 | author | Gen Inoue | Q42177740 |
| Miyako Suzuki | Q60329316 | ||
| Yawara Eguchi | Q64748075 | ||
| Kazuhide Inage | Q86789034 | ||
| Seiji Ohtori | Q87650194 | ||
| Sumihisa Orita | Q87650196 | ||
| Koki Abe | Q88323562 | ||
| Masayuki Miyagi | Q88526236 | ||
| Kazuhisa Takahashi | Q88526240 | ||
| Kazuki Fujimoto | Q88596385 | ||
| Yasuhiro Shiga | Q88596387 | ||
| Yoshitaka Aoki | Q88601298 | ||
| Junichi Nakamura | Q90319203 | ||
| Kazuyo Yamauchi | Q98113652 | ||
| Kazuki Kuniyoshi | Q114323826 | ||
| Nobuyasu Ochiai | Q114717097 | ||
| Takeshi Sainoh | Q114717110 | ||
| Gou Kubota | Q114717122 | ||
| Hiroto Kanamoto | Q114717152 | ||
| P2093 | author name string | Jun Sato | |
| P2860 | cites work | Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis | Q29619487 |
| Fracture Incidence, Quality of Life, and Back Pain during 18-Months Treatment with Teriparatide in Greek Postmenopausal Women with Osteoporosis: Results from the European Forsteo Observational Study | Q35222686 | ||
| Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial | Q37001737 | ||
| Teriparatide: a review of its use in osteoporosis. | Q37354140 | ||
| An update on bone substitutes for spinal fusion | Q37413018 | ||
| Can bone morphogenetic protein binding peptide increase efficiency of bone formation? | Q37772384 | ||
| Diagnostic criteria for primary osteoporosis: year 2012 revision | Q38095829 | ||
| Degenerative lumbar spondylolisthesis with spinal stenosis. A prospective study comparing decompression with decompression and intertransverse process arthrodesis | Q39508342 | ||
| Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label ph | Q42665480 | ||
| Comparison of teriparatide and bisphosphonate treatment to reduce pedicle screw loosening after lumbar spinal fusion surgery in postmenopausal women with osteoporosis from a bone quality perspective | Q46200666 | ||
| Teriparatide accelerates lumbar posterolateral fusion in women with postmenopausal osteoporosis: prospective study | Q47292163 | ||
| 1997 Volvo Award winner in clinical studies. Degenerative lumbar spondylolisthesis with spinal stenosis: a prospective, randomized study comparing decompressive laminectomy and arthrodesis with and without spinal instrumentation | Q48382549 | ||
| Nationwide trends in the surgical management of lumbar spinal stenosis. | Q51203559 | ||
| Teriparatide may accelerate healing in delayed unions of type III odontoid fractures: a report of 3 cases. | Q53315960 | ||
| Enhancement of graft bone healing by intermittent administration of human parathyroid hormone (1-34) in a rat spinal arthrodesis model. | Q53467886 | ||
| Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study | Q74590315 | ||
| Effect of teriparatide [rhPTH(1,34)] and calcitonin on intertransverse process fusion in a rabbit model | Q82545763 | ||
| Parathyroid hormone (1-34) augments spinal fusion, fusion mass volume, and fusion mass quality in a rabbit spinal fusion model | Q83105705 | ||
| Teriparatide for acceleration of fracture repair in humans: a prospective, randomized, double-blind study of 102 postmenopausal women with distal radial fractures | Q84211314 | ||
| Parathyroid hormone 1-84 accelerates fracture-healing in pubic bones of elderly osteoporotic women | Q84940845 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P304 | page(s) | 573-580 | |
| P577 | publication date | 2015-07-28 | |
| P1433 | published in | Asian Spine Journal | Q26842187 |
| P1476 | title | More than 6 Months of Teriparatide Treatment Was More Effective for Bone Union than Shorter Treatment Following Lumbar Posterolateral Fusion Surgery | |
| P478 | volume | 9 |
| Q92279921 | A Review and Clinical Perspective of the Impact of Osteoporosis on the Spine |
| Q97419405 | Abaloparatide and the Spine: A Narrative Review |
| Q52600423 | Anabolic agents: what is beyond osteoporosis? |
| Q33826620 | Bisphosphonate's and Intermittent Parathyroid Hormone's Effect on Human Spinal Fusion: A Systematic Review of the Literature |
| Q38819859 | Does Discontinuing Teriparatide Treatment and Replacing It with Bisphosphonate Maintain the Volume of the Bone Fusion Mass after Lumbar Posterolateral Fusion in Women with Postmenopausal Osteoporosis? |
| Q55418444 | Effect of an intensive conservative therapy with daily teriparatide administration and rehabilitation for osteoporotic delayed vertebral collapse and paralysis. |
| Q47670782 | Effects of combined teriparatide and zoledronic acid on posterior lumbar vertebral fusion in an aged ovariectomized rat model of osteopenia. |
| Q64104312 | Investigational growth factors utilized in animal models of spinal fusion: Systematic review |
| Q40908172 | Medication and bone metabolism: Clinical importance for fracture treatment |
| Q92761338 | Nonunion of Transpsoas Lateral Lumbar Interbody Fusion Using an Allograft: Clinical Assessment and Risk Factors |
| Q37626650 | Retrospective radiological outcome analysis following teriparatide use in elderly patients undergoing multilevel instrumented lumbar fusion surgery |
| Q57168746 | The Biological Enhancement of Spinal Fusion for Spinal Degenerative Disease |
| Q88425853 | The Effects of High-Dose Parathyroid Hormone Treatment on Fusion Outcomes in a Rabbit Model of Posterolateral Lumbar Spinal Fusion Alone and in Combination with Bone Morphogenetic Protein 2 Treatment |
Search more.